Adamax
A product name for a peptide sold as a Semax-derived analogue. Its exact structure is not established in peer-reviewed literature, and no studies of a compound under this name are indexed on PubMed.
Research blend
Size
1 option- Catalog no.
- AD5
- Specification
- 5mg*10vials
- Per kit
- 10 vials
For laboratory research use only. Not for human or animal consumption. Buyers must be 21 or older.
Overview
Adamax is a vendor name rather than a scientific or regulatory designation. Sellers and informal reference sites describe it as an analogue of Semax, the ACTH(4-10)-based heptapeptide, with added terminal modifications; some listings mention an adamantane-containing group. These sources give conflicting sequences and molecular formulas, and no peer-reviewed characterization has been published, so the exact formulation is not specified. Claims about its potency or stability relative to Semax are not supported by indexed studies. The parent compound, Semax, has a separate body of mostly Russian rodent and clinical research.
Class: Vendor-named Semax-derived analogue (structure not established)
Mechanism of action
How the compound acts, as described in the literature.
No pharmacological studies of Adamax are indexed; its receptor targets, stability, and activity have not been characterized in published research.
Any proposed mechanism is extrapolated from Semax, which in rats increased hippocampal BDNF and trkB expression and altered immune- and vascular-related gene expression after cerebral ischemia.
Whether the terminal modifications attributed to Adamax preserve, enhance, or abolish Semax-like activity has not been tested.
Published research
Selected studies, each linked to its PubMed record. Summaries describe what the studies reported.
The exact formulation of this product has not been specified, so no peer-reviewed study can be attributed to it.
Evidence & safety
What the research does not show, and the adverse events and regulatory status it reports.
No indexed study has characterized a compound called Adamax, and published descriptions of its structure conflict, so its pharmacology and safety are unknown. Findings for Semax cannot be assumed to apply, and Adamax is not an approved medicine.
Specifications
All sizes, exactly as catalogued.
| Catalog no. | Product | Specification | Vials per kit |
|---|---|---|---|
| AD5 | Adamax | 5mg*10vials | 10 |
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease. Research summaries are provided for educational purposes and do not describe this product’s use.